| Title | Chloride channelopathies. | | Author(s) | Planells-Cases R, Jentsch TJ | | Institution | Centro de Investigación Príncipe Felipe, Valencia, Spain. rplanells@ochoa.fib.es | | Source | Biochim Biophys Acta 2009 Mar; 1792(3):173-89. | | Abstract | Channelopathies, defined as diseases that are caused by mutations in genes encoding ion channels, are associated with a wide variety of symptoms. Impaired chloride transport can cause diseases as diverse as cystic fibrosis, myotonia, epilepsy, hyperekplexia, lysosomal storage disease, deafness, renal salt loss, kidney stones and osteopetrosis. These disorders are caused by mutations in genes belonging to non-related gene families, i.e. CLC chloride channels and transporters, ABC transporters, and GABA- and glycine receptors. Diseases due to mutations in TMEM16E and bestrophin 1 might be due to a loss of Ca++-activated Cl- channels, although this remains to be shown. | | Language | eng | | Pub Type(s) | Journal Article
Research Support, Non-U.S. Gov't
| | PubMed ID | 19708126 |
|
